In vivo regulation of μ-opioid receptor
✍
Alokesh Duttaroy; Byron C. Yoburn
📂
Article
📅
2000
🏛
John Wiley and Sons
🌐
English
⚖ 92 KB
Chronic in vivo treatment with the opioid agonist etorphine downregulates mu-opioid receptor density, produces tolerance, and regulates gene expression in the mouse. After cessation of treatment, there is an increase in mu-opioid receptor mRNA level associated with the recovery of mu-opioid receptor